148 related articles for article (PubMed ID: 36082986)
1. Transplantation for Nonresectable Colorectal Liver Metastases: Long-Term Follow-Up of the First Prospective Pilot Study.
Solheim JM; Dueland S; Line PD; Hagness M
Ann Surg; 2023 Aug; 278(2):239-245. PubMed ID: 36082986
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial.
Dueland S; Smedman TM; Syversveen T; Grut H; Hagness M; Line PD
JAMA Surg; 2023 Sep; 158(9):e232932. PubMed ID: 37494056
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for nonresectable liver metastases from colorectal cancer.
Hagness M; Foss A; Line PD; Scholz T; Jørgensen PF; Fosby B; Boberg KM; Mathisen O; Gladhaug IP; Egge TS; Solberg S; Hausken J; Dueland S
Ann Surg; 2013 May; 257(5):800-6. PubMed ID: 23360920
[TBL] [Abstract][Full Text] [Related]
4. Survival Outcomes After Portal Vein Embolization and Liver Resection Compared With Liver Transplant for Patients With Extensive Colorectal Cancer Liver Metastases.
Dueland S; Yaqub S; Syversveen T; Carling U; Hagness M; Brudvik KW; Line PD
JAMA Surg; 2021 Jun; 156(6):550-557. PubMed ID: 33787838
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?
Dueland S; Guren TK; Hagness M; Glimelius B; Line PD; Pfeiffer P; Foss A; Tveit KM
Ann Surg; 2015 May; 261(5):956-60. PubMed ID: 24950280
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study).
Smedman TM; Line PD; Hagness M; Syversveen T; Grut H; Dueland S
BJS Open; 2020 Jun; 4(3):467-477. PubMed ID: 32333527
[TBL] [Abstract][Full Text] [Related]
7. Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases.
Dueland S; Syversveen T; Solheim JM; Solberg S; Grut H; Bjørnbeth BA; Hagness M; Line PD
Ann Surg; 2020 Feb; 271(2):212-218. PubMed ID: 31188200
[TBL] [Abstract][Full Text] [Related]
8. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
9. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.
Adam R; Delvart V; Pascal G; Valeanu A; Castaing D; Azoulay D; Giacchetti S; Paule B; Kunstlinger F; Ghémard O; Levi F; Bismuth H
Ann Surg; 2004 Oct; 240(4):644-57; discussion 657-8. PubMed ID: 15383792
[TBL] [Abstract][Full Text] [Related]
10. Is Liver Transplantation an Option in Colorectal Cancer Patients with Nonresectable Liver Metastases and Progression on All Lines of Standard Chemotherapy?
Dueland S; Hagness M; Line PD; Guren TK; Tveit KM; Foss A
Ann Surg Oncol; 2015 Jul; 22(7):2195-200. PubMed ID: 25297902
[TBL] [Abstract][Full Text] [Related]
11. Patterns of recurrence after liver transplantation for nonresectable liver metastases from colorectal cancer.
Hagness M; Foss A; Egge TS; Dueland S
Ann Surg Oncol; 2014 Apr; 21(4):1323-9. PubMed ID: 24370906
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score.
Lanari J; Hagness M; Sartori A; Rosso E; Gringeri E; Dueland S; Cillo U; Line PD
Transpl Int; 2021 Sep; 34(9):1722-1732. PubMed ID: 34448271
[TBL] [Abstract][Full Text] [Related]
13. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.
Okuno M; Hatano E; Toda R; Nishino H; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokuka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
J Hepatobiliary Pancreat Sci; 2020 Aug; 27(8):496-509. PubMed ID: 32362018
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
Leung U; Gönen M; Allen PJ; Kingham TP; DeMatteo RP; Jarnagin WR; D'Angelica MI
Ann Surg; 2017 Jan; 265(1):158-165. PubMed ID: 28009741
[TBL] [Abstract][Full Text] [Related]
16. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
[TBL] [Abstract][Full Text] [Related]
17. Effect of Time to Surgery of Colorectal Liver Metastases on Survival.
Chen EY; Mayo SC; Sutton T; Kearney MR; Kardosh A; Vaccaro GM; Billingsley KG; Lopez CD
J Gastrointest Cancer; 2021 Mar; 52(1):169-176. PubMed ID: 32086781
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
[TBL] [Abstract][Full Text] [Related]
19. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
[TBL] [Abstract][Full Text] [Related]
20. Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?
Creasy JM; Sadot E; Koerkamp BG; Chou JF; Gonen M; Kemeny NE; Balachandran VP; Kingham TP; DeMatteo RP; Allen PJ; Blumgart LH; Jarnagin WR; D'Angelica MI
Surgery; 2018 Jun; 163(6):1238-1244. PubMed ID: 29455841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
